Cargando…

CSACI position statement: transition recommendations on existing epinephrine autoinjectors

Epinephrine is the first line treatment for anaphylaxis, an acute potentially life-threatening allergic reaction. It is typically administered intramuscularly in the anterolateral thigh at a dose of 0.01 mg/kg of 1:1000 (1 mg/ml) solution to a maximum initial dose of 0.5 mg. Currently in Canada, epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lucy Dong Xuan, Abrams, Elissa M., Lavine, Elana, Hildebrand, Kyla, Mack, Douglas Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Position Article and Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670273/ https://www.ncbi.nlm.nih.gov/pubmed/34903280 http://dx.doi.org/10.1186/s13223-021-00634-2

Ejemplares similares

Early introduction is not enough: CSACI statement on the importance of ongoing regular ingestion as a means of food allergy prevention
por: Abrams, Elissa M., et al.
Publicado: (2023)

CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma
por: Issa-El-Khoury, Karine, et al.
Publicado: (2015)

CSACI position statement: epinephrine auto-injectors and children < 15 kg
por: Halbrich, Michelle, et al.
Publicado: (2015)

CSACI Position statement on the testing of food-specific IgG
por: Carr, Stuart, et al.
Publicado: (2012)

COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)
por: Vander Leek, Timothy K., et al.
Publicado: (2021)

Adherence with epinephrine autoinjector prescriptions in primary care
por: Abrams, Elissa M., et al.
Publicado: (2017)

Dietary exposures and allergy prevention in high-risk infants
por: Abrams, Elissa M., et al.
Publicado: (2022)

The pharmacokinetics of epinephrine/adrenaline autoinjectors
por: Dreborg, Sten, et al.
Publicado: (2021)

Position statement for the diagnosis and management of anogenital warts
por: O'Mahony, C., et al.
Publicado: (2019)

Dietary exposures and allergy prevention in high-risk infants: a joint position statement of the Canadian Society of Allergy and Clinical Immunology and the Canadian Paediatric Society
por: Chan, Edmond S, et al.
Publicado: (2014)

Nutritional treatment of advanced CKD: twenty consensus statements
por: Cupisti, Adamasco, et al.
Publicado: (2018)

Accidental Digital Ischemia by an Epinephrine Autoinjector
por: Nayaz, Mohamed, et al.
Publicado: (2023)

The biodiversity hypothesis and allergic disease: world allergy organization position statement
por: Haahtela, Tari, et al.
Publicado: (2013)

Allergen immunotherapy on the way to product-based evaluation—a WAO statement
por: Bachert, Claus, et al.
Publicado: (2015)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
por: McNeel, Douglas G., et al.
Publicado: (2016)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
por: Shah, Nina, et al.
Publicado: (2020)

EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements
por: Golubnitschaja, Olga, et al.
Publicado: (2015)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
por: Rini, Brian I., et al.
Publicado: (2016)

Green nephrology and eco-dialysis: a position statement by the Italian Society of Nephrology
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2020)

Position Statement on Atopic Dermatitis in Sub‐Saharan Africa: current status and roadmap
por: Schmid‐Grendelmeier, P., et al.
Publicado: (2019)

Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices
por: Herman, A., et al.
Publicado: (2021)

COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
por: Puig-Domingo, M., et al.
Publicado: (2021)

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement
por: Gambaro, Giovanni, et al.
Publicado: (2016)

The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
por: Taube, Janis M, et al.
Publicado: (2020)

Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020
por: Javeri, Yash, et al.
Publicado: (2020)

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
por: Rini, Brian I., et al.
Publicado: (2019)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement
por: Tsimberidou, Apostolia M., et al.
Publicado: (2018)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Indian Society of Critical Care Medicine Experts Committee Consensus Statement on ICU Planning and Designing, 2020
por: Rungta, Narendra, et al.
Publicado: (2020)

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
por: Quirt, J., et al.
Publicado: (2018)

Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes
por: Dribin, Timothy E., et al.
Publicado: (2023)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2016)

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
por: Sullivan, Ryan J., et al.
Publicado: (2018)

A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy
por: Cabiddu, Gianfranca, et al.
Publicado: (2016)

Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology
por: Attini, Rossella, et al.
Publicado: (2020)

APASL consensus statements and recommendation on treatment of hepatitis C
por: Omata, Masao, et al.
Publicado: (2016)

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement
por: Leshem, Y.A., et al.
Publicado: (2019)

Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas
por: Grob, J.J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_it720v702pl7v8r60suu7s45s2